mainboard • BSE, NSE
Corona Remedies
₹300.01
Est. listing gain: 28.25%
Last updated: 2 Jan 2026 12:03 am
Overall Subscription Details: 144.49 times
Open
Dec 8, 2025
Close
Dec 10, 2025
BOA
11 Dec 2025
Refunds
12 Dec 2025
Listing
15 Dec 2025
Pricing & Lot
Price Band
₹1008-1062
Face Value
₹10 Per Equity Share
Lot Size
TBA
Managers & Listing
Listing At
BSE, NSE
Lead Managers
JM Financial Ltd IIFL Capital Services Ltd Kotak Mahindra Capital Co.Ltd Kotak Mahindra Capital Co.Ltd.
Registrar
Bigshare Services Pvt Ltd
Issue Size
61,71,101 shares(aggregating up to ₹655.37 crore)
| Investor Category | Shares Offered | Percentage |
|---|---|---|
| Anchor Investor Shares Offered | 1834804 (29.73%) | 29.73% |
| QIB Shares Offered | 1221729 (19.8%) | 19.80% |
| NII (HNI) Shares Offered | 916960 (14.86%) | 14.86% |
| bNII > ₹10L | 611307 (10%) | 10.00% |
| sNII < ₹10L | 305653 (5%) | 5.00% |
| Retail Shares Offered | 2139573 (10%) | 10.00% |
| Employee Shares Offered | 58036 (0.94%) | 0.94% |
| Total Shares Offered | 6171101 (100%) | 100.00% |
GMP (per share)
₹300.01
Est. Listing Price
₹1362.01
Total Listing Gain (per lot)
₹0.00
Grey Market Premium (GMP) is an unofficial market indicator. It reflects the premium investors are willing to pay over the issue price before listing. This is not a guaranteed return and can change rapidly.
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
Name
Bigshare Services Pvt Ltd
Phone
+91-22-6263 8200GainIPO data last updated: 01 Jan 2026, 06:33 PM IST